Here are comprehensive, exam-oriented notes from the Shanbhag Pharmacology source on Autacoids and Respiratory System (Histamine, Antihistamines, 5-HT, Migraine, Prostaglandins & Leukotrienes):
π AUTACOIDS & RESPIRATORY SYSTEM β EXAM NOTES
(Shanbhag Pharmacology)
PART 1: HISTAMINE & ANTIHISTAMINES
β AUTACOIDS β Quick Definition
- Produced by cells, act locally β also called "local hormones"
- Examples: Histamine, Serotonin (5-HT), Prostaglandins, Leukotrienes, Angiotensin, Kinins, PAF
β HISTAMINE β Key Points
- Biogenic amine; synthesized by decarboxylation of histidine
- Stored in mast cell granules (skin, lung, liver, gastric mucosa, placenta)
- Mediator of inflammatory and hypersensitivity reactions
HISTAMINE RECEPTORS β HIGH YIELD TABLE
| Receptor | 2nd Messenger | Effect |
|---|
| H1 | β CaΒ²βΊ | Smooth muscle contraction, β capillary permeability |
| H2 | β cAMP | β Gastric acid secretion |
| H3 (presynaptic autoreceptor) | β cAMP | β Histamine in brain, lung, skin, gastric mucosa |
| H4 | β cAMP | Chemotaxis, cytokine secretion |
HISTAMINE LIBERATORS
- AG:AB reaction, food (crab, fish), bile salts
- Drugs: Morphine, d-TC, dextran, hydralazine
- Effects: itching, urticaria, flushing, hypotension, tachycardia, bronchospasm, angioedema
BETAHISTINE (Histamine Analogue)
- Used orally for vertigo in Meniere's disease
- Mechanism: improves blood flow in inner ear
- Side effects: nausea, vomiting, headache, pruritus
- Avoid in: asthma, peptic ulcer
β H1-RECEPTOR ANTAGONISTS (ANTIHISTAMINES)
CLASSIFICATION
First Generation (Conventional):
Diphenhydramine, Dimenhydrinate, Promethazine, Cinnarizine, Cyclizine, Meclizine, Hydroxyzine, Pheniramine, Chlorpheniramine maleate, Cyproheptadine, Clemastine, Triprolidine
Second Generation (Non-sedating):
Cetirizine, Levocetirizine, Azelastine, Mizolastine, Loratadine, Desloratadine, Fexofenadine, Ebastine, Rupatadine
MECHANISM OF ACTION
- Competitive antagonism at H1 receptors
- Histamine (agonist) β H1 Receptors β Antihistamines (antagonists)
FIRST-GENERATION H1-BLOCKERS β Properties
Pharmacological Actions:
- CNS depression - sedation, drowsiness (some have antiemetic, local anaesthetic, anti-parkinsonian effects)
- Antiallergic - suppress Type I reactions
- Anticholinergic - dry mouth, blurred vision, constipation, urinary retention
Pharmacokinetics:
- Well absorbed orally and parenterally
- Widely distributed, metabolized in liver, excreted in urine
Adverse Effects:
- Sedation, drowsiness, psychomotor incoordination β avoid while driving/operating machinery
- GI: nausea, vomiting, loss of appetite
- Anticholinergic: dry mouth, blurred vision, constipation, urinary retention
- Teratogenic (in animals)
- Allergic reactions (contact dermatitis on topical use)
USES OF FIRST-GENERATION ANTIHISTAMINES
| Use | Drug(s) |
|---|
| Allergic diseases (urticaria, rhinitis, conjunctivitis) | All H1-blockers |
| Common cold (symptomatic relief) | Sedating antihistamines |
| Preanesthetic medication | Promethazine |
| Antiemetic | Promethazine, Diphenhydramine, Dimenhydrinate |
| Parkinsonism | Promethazine, Diphenhydramine, Orphenadrine |
| Vertigo (Meniere's) | Cinnarizine, Dimenhydrinate, Meclizine |
| Sedation/Hypnotic (children, minor surgery) | Promethazine, Diphenhydramine |
| Blood transfusion reactions (chills, rigors) | H1-blockers |
| Anaphylaxis (adjunct) | H1-blockers |
Antiemetic Mechanism:
Motion β Vestibular apparatus (M, H1) β Cerebellum β Vomiting centre (M, H1)
Parkinsonism: Due to imbalance between DA (β) and ACh (β) in basal ganglia
SECOND-GENERATION H1-BLOCKERS β Properties
- No anticholinergic effects
- Lack antiemetic effect
- Do not cross BBB β minimal/no drowsiness
- Do not impair psychomotor performance
- Relatively expensive
SECOND-GEN DRUGS β INDIVIDUAL FEATURES (HIGH YIELD)
| Drug | Route/Duration | Key Features |
|---|
| Cetirizine | p.o., 12-24 hr | Also inhibits histamine release; good skin concentration; poorly crosses BBB; may cause drowsiness |
| Levocetirizine | p.o., 12-24 hr | More potent, fewer adverse effects than cetirizine |
| Loratadine/Desloratadine | p.o., 24 hr | Long-acting, nonsedating; no cardiac arrhythmias |
| Fexofenadine | p.o., 12-24 hr | Active metabolite of terfenadine; nonsedating; avoid in prolonged QT interval |
| Azelastine | Topical (nasal spray, eye drops) | Also inhibits histamine release; rapid onset, long duration; taste alteration, burning sensation |
| Rupatadine | p.o. | H1-blocker + blocks platelet-activating factor |
Uses of 2nd-gen: Rhinitis, dermatitis, conjunctivitis, urticaria, eczema, drug/food allergies
- For allergic rhinitis: fexofenadine, cetirizine, mizolastine, rupatadine (oral); azelastine (nasal spray)
- Eye drops for allergic conjunctivitis: azelastine, levocabastine
β ANTIVERTIGO DRUGS β Summary
- Cinnarizine (1st-gen H1, decreases CaΒ²βΊ entry into vestibular cells)
- Promethazine, Diphenhydramine (H1-blockers)
- Hyoscine (anticholinergic)
- Prochlorperazine (phenothiazine)
- Betahistine (H1-analogue)
- Acetazolamide, thiazides, furosemide (diuretics)
- Diazepam
- Amitriptyline (TCA)
- Glucocorticoids
PART 2: SEROTONIN (5-HT) β AGONISTS & ANTAGONISTS
β KEY FACTS ABOUT 5-HT
- Synthesized from tryptophan (amino acid)
- High concentration in: intestine, platelets, brain
- 7 subtypes of receptors (5-HT1β7); all G-protein coupled except 5-HT3 (ligand-gated ion channel)
5-HT RECEPTOR TABLE (HIGH YIELD)
| Receptor | Location | Actions | Drugs |
|---|
| 5-HT1 | CNS, cranial blood vessels | β 5-HT release (autoreceptors); constriction of cranial blood vessels | Buspirone (partial agonist); Triptans (selective 5-HT1B/1D agonists); Ergotamine |
| 5-HT2 | Platelets, smooth muscles, cerebral cortex, fundus, choroid | Platelet aggregation, smooth muscle contraction, neuron activation, CSF production | Ketanserin (antagonist); Cyproheptadine (antagonist); Methysergide; Atypical antipsychotics |
| 5-HT3 | CTZ, NTS, parasympathetic nerve terminals (GIT) | Vomiting, peristalsis | Ondansetron, Granisetron (antagonists) |
| 5-HT4 | GIT, CNS | Peristalsis | Metoclopramide, Prucalopride (agonists) |
5-HT ANTAGONISTS β SUMMARY
| Drug | Action | Use/Notes |
|---|
| Cyproheptadine | H1 + 5-HT2A blocker; anticholinergic | Carcinoid syndrome, postgastrectomy dumping; increases appetite; side effects: dry mouth, drowsiness, weight gain |
| Ketanserin | 5-HT2A antagonist + Ξ±1-blocker | Antihypertensive effect |
| Ondansetron/Granisetron | 5-HT3 antagonists | Antiemetics |
| Clozapine, Olanzapine, Quetiapine, Risperidone | 5-HT2 blockers | Schizophrenia (atypical antipsychotics) |
| Methysergide | 5-HT2A/2C antagonist | Prophylaxis of migraine (long-term use β abdominal and pulmonary fibrosis) |
ERGOT ALKALOIDS
| Drug | Receptor Action | Effects | Use | ADR |
|---|
| Ergotamine (natural) | Partial agonist/antagonist at Ξ±, 5-HT1, 5-HT2 | Smooth muscle contraction (blood vessels, uterus, gut) | Acute migraine (oral, sublingual, suppository, rectal) | Vomiting, diarrhoea; overdose β severe vasospasm β gangrene |
| Dihydroergotamine (DHE) | Predominant Ξ±-blockade; weak 5-HT and Ξ±-agonist | Less vasoconstriction than ergotamine | Acute migraine (oral, i.m., s.c.) | Nausea, vomiting |
| Ergometrine (natural) | Partial agonist at 5-HT2; weak action at Ξ±-receptors | Major action: uterine contraction; minimal vasoconstriction | Postpartum haemorrhage (i.m., i.v.) | Nausea, vomiting, rise in BP |
| Bromocriptine (semi-synthetic) | D2-agonist | Decreases prolactin release | Parkinsonism, galactorrhoea (oral) | Vomiting, hypotension |
Contraindications of Ergot Alkaloids: Ischaemic heart disease, hypertension, peripheral vascular disease, renal disease
PART 3: DRUG THERAPY OF MIGRAINE β
Migraine Attack: aura (visual disturbance) β severe throbbing headache with photophobia, nausea, vomiting
DRUGS FOR ACUTE ATTACK
1. NSAIDs (mild-moderate migraine): Paracetamol, aspirin, ibuprofen, naproxen, diclofenac, mefenamic acid
2. Antiemetics (oral/parenteral): Metoclopramide, Domperidone, Prochlorperazine, Promethazine, Diphenhydramine
3. Ergot Preparations:
- Ergotamine: partial agonist at 5-HT1B/1D β constricts dilated cranial blood vessels + decreases inflammation
- Combined with caffeine (increases absorption + vasoconstriction)
- DHE (Dihydroergotamine): safer for parenteral use (i.m., i.v., s.c.)
4. Triptans (DRUGS OF CHOICE for moderate-severe migraine):
Examples: Sumatriptan, Rizatriptan, Eletriptan, Almotriptan, Zolmitriptan, Naratriptan, Frovatriptan
Mechanism: Selective 5-HT1B/1D agonists
- Abnormal dilatation of cranial blood vessels β Cerebral ischaemia β Migraine attack
- Triptans β constrict dilated cranial blood vessels + AV shunts β Restore cerebral blood flow
- Also: decrease 5-HT and vasoactive peptide release from presynaptic nerve endings
- Inhibit extravasation of plasma proteins in perivascular space
Route: All oral; Sumatriptan also s.c. and nasal; Zolmitriptan also nasal
Half-life: Sumatriptan = 2 hours; Frovatriptan and Naratriptan = longer half-life
Adverse Effects of Triptans: Paraesthesia, tightness/flushing/dizziness in chest, nausea, rise in BP, coronary vasospasm
Contraindications of Triptans:
- Pregnancy
- Ischaemic heart disease
- Peripheral vascular disease
- Hypertension
- Risk factors for coronary artery disease
- Triptan + Ergot = NOT together (neither within 24 hours of ergot derivative)
PROPHYLAXIS OF MIGRAINE (Note ABCD β HIGH YIELD)
| Letter | Drug Class | Examples |
|---|
| A | Antidepressants (TCAs) | Amitriptyline |
| B | Beta-blockers | Propranolol, Timolol, Atenolol, Metoprolol (Propranolol most effective) |
| C | Calcium channel blockers | Verapamil, Flunarizine (selective for cerebral; also NaβΊ channel blocking) |
| D | Anticonvulsants ("D"rugs for epilepsy) | Gabapentin, Sodium valproate, Topiramate |
| Others | | Methysergide, Cyproheptadine (rarely used) |
Note: CCBs should NOT be co-administered with Ξ²-blockers. Flunarizine is selective for cerebral CaΒ²βΊ channels.
PART 4: PROSTAGLANDINS (PGs) & LEUKOTRIENES β
KEY FACTS
- Products of long-chain fatty acids
- Precursor: Arachidonic acid
- Enzyme: Cyclooxygenase (COX) forms PGs from arachidonic acid
- COX-1: Constitutive (always present); widely distributed
- COX-2: Inducible during inflammation (by cytokines and endotoxins); also constitutively found in brain and kidney
- Leukotrienes: obtained from arachidonic acid by lipoxygenase (LOX)
PHARMACOLOGICAL ACTIONS & USES (HIGH YIELD)
1. GI Tract:
- PGE2 and PGI2: β acid secretion, β mucus secretion (cytoprotective)
- Misoprostol (PGE1 analogue): used for prevention of NSAID-induced ulcers
2. Cardiovascular:
- PGD2, PGE2, PGI2: vasodilation
- PGF2Ξ±: constricts pulmonary veins and arteries
- TXA2: vasoconstrictor
- PGE1 (Alprostadil): maintains patency of ductus arteriosus before surgery
3. Pulmonary hypertension:
- Prostacyclin (PGI2) β decreases peripheral, pulmonary, coronary resistance
- PGI2 (Epoprostenol): treats pulmonary hypertension; analogues: Treprostinil, Iloprost
4. Platelets:
- PGI2: inhibits platelet aggregation (useful in haemodialysis)
- TXA2: promotes aggregation
5. Eye:
- PGF2Ξ± analogues (Latanoprost, Bimatoprost, Travoprost, Unoprostone): used in glaucoma (topical eye drops, β IOP)
6. Uterus:
- PGE2 (low conc.) and PGF2Ξ±: contract pregnant uterus
- Used in mid-trimester abortion, missed abortion, hydatidiform mole
- PGE2 and PGF2Ξ±: induce labour at term; promote cervical ripening
7. Male reproductive system:
- PGE1 (Alprostadil): used in erectile dysfunction
PROSTAGLANDIN ANALOGUES β TABLE (HIGH YIELD)
| Drug | Type | Route | Use |
|---|
| Dinoprostone (PGE2) | PGE2 | Vaginal tab/gel | Induction of labour, mid-term abortion, termination of pregnancy |
| Dinoprost (PGF2Ξ±) | PGF2Ξ± | Intra-amniotic injection | Mid-term abortion |
| Carboprost (15-methyl PGF2Ξ±) | PGF2Ξ± analogue | i.m. | Mid-term abortion, control of PPH |
| Gemeprost (PGE1) | PGE1 | Vaginal pessary | Cervical priming in early pregnancy |
| Alprostadil (PGE1) | PGE1 | i.v. infusion, intracavernosal | Maintain ductus arteriosus; erectile dysfunction |
| Misoprostol (PGE2) | PGE2 analogue | Oral, vaginal pessary | Peptic ulcer, abortion, PPH |
| Epoprostenol/Treprostinil/Iloprost (PGI2) | PGI2 | i.v. infusion | Pulmonary hypertension |
| Latanoprost/Bimatoprost/Unoprostone/Travoprost (PGF2Ξ±) | PGF2Ξ± | Topical (eye drops) | Glaucoma |
THERAPEUTIC USES IN OBSTETRICS
- Abortion: Dinoprostone, Misoprostol (+mifepristone/methotrexate), Carboprost (2nd trimester), Gemeprost and Dinoprost
- Induction of labour: PGE2 (softens cervix)
- PPH: Carboprost (i.m.) and Misoprostol (oral)
Adverse Effects of PGs: Nausea, vomiting, diarrhoea, fever, flushing, hypotension, backache (due to uterine contractions); injections painful due to nerve sensitization
LEUKOTRIENES
- Obtained from arachidonic acid by lipoxygenase
- Leukotriene antagonists: see p. 259 (Montelukast, Zafirlukast β used in asthma)
β QUICK-FIRE HIGH YIELD FACTS (EXAM SHORTCUTS)
| Fact | Answer |
|---|
| Histamine is synthesized from | Histidine |
| Histamine stored in | Mast cell granules |
| H1 receptor 2nd messenger | CaΒ²βΊ |
| H2 receptor 2nd messenger | cAMP (β) |
| H3 receptor | Presynaptic autoreceptor; β cAMP |
| Betahistine used for | Vertigo in Meniere's disease |
| 1st-gen antihistamine for antiemetic | Promethazine, Dimenhydrinate |
| 1st-gen antihistamine for vertigo | Cinnarizine, Dimenhydrinate, Meclizine |
| 2nd-gen antihistamine causing drowsiness | Cetirizine (mildly) |
| Only 5-HT receptor that is NOT G-protein coupled | 5-HT3 (ligand-gated) |
| 5-HT3 antagonists (antiemetics) | Ondansetron, Granisetron |
| Drug of choice β acute severe migraine | Triptans (5-HT1B/1D agonists) |
| Triptan with shortest half-life | Sumatriptan (2 hours) |
| Triptan + ergot contraindication | Never within 24 hours of each other |
| Best beta-blocker for migraine prophylaxis | Propranolol |
| COX-1 vs COX-2 | COX-1 = constitutive; COX-2 = inducible by inflammation |
| Precursor for PGs and leukotrienes | Arachidonic acid |
| Enzyme for PGs | COX (Cyclooxygenase) |
| Enzyme for Leukotrienes | Lipoxygenase |
| Misoprostol used for | NSAID-induced ulcers, abortion, PPH |
| Alprostadil (PGE1) used for | Ductus arteriosus patency, erectile dysfunction |
| PGI2 analogue for pulmonary hypertension | Epoprostenol, Treprostinil, Iloprost |
| PGF2Ξ± eye drops for glaucoma | Latanoprost, Bimatoprost, Travoprost |
| Carboprost used for | Mid-term abortion + PPH control |
| Methysergide long-term side effect | Abdominal and pulmonary fibrosis |
| Rupatadine unique feature | H1-blocker + blocks platelet-activating factor |
| Fexofenadine is active metabolite of | Terfenadine |
Exam Tip: Remember migraine prophylaxis as "ABCD" β Antidepressants, Beta-blockers, Calcium channel blockers, Drugs (anticonvulsants). Triptans are preferred for acute moderate-severe attacks. Never combine Triptans with Ergot preparations.